Get the Stockscreener App
0.00
100.00%
-5.38
After Hours:
5.38
5.38
+
Third Harmonic Bio Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
See More
Previous Close:
$5.38
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$242.79M
Revenue:
-
Net Income/Loss:
$-32.74M
P/E Ratio:
0.00
EPS:
-0.82
Net Cash Flow:
$-24.89M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.50
Third Harmonic Bio Inc Stock (THRD) Company Profile
Name
Third Harmonic Bio Inc
Sector
Industry
Phone
(209) 727-2457
Address
1700 MONTGOMERY STREET, SAN FRANCISCO
Compare THRD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THRD
Third Harmonic Bio Inc
|
0.00 | 242.79M | 0 | -32.74M | -24.89M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-12-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-11-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-09-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-18-24 | Initiated | Stifel | Buy |
| Jun-07-24 | Initiated | Raymond James | Outperform |
| Dec-16-22 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-10-22 | Initiated | Cowen | Outperform |
| Oct-10-22 | Initiated | Jefferies | Buy |
| Oct-10-22 | Initiated | Morgan Stanley | Overweight |
View All
Third Harmonic Bio Inc Stock (THRD) Latest News
Pattern recognition hints at Third Harmonic Bio Inc. upside2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Third Harmonic Bio Inc Stock Analysis and ForecastStochastic Oscillator Alerts & Small Investment Growth Tips - earlytimes.in
Third Harmonic stock rating cut by Raymond James - MSN
Is Third Harmonic Bio Inc. stock cheap at current valuationWeekly Trade Report & Detailed Earnings Play Strategies - newser.com
How to build a custom watchlist for Third Harmonic Bio Inc.Insider Buying & Comprehensive Market Scan Insights - newser.com
Third Harmonic Bio Inc. stock prediction for this week2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What moving averages say about Third Harmonic Bio Inc.Day Trade & Reliable Breakout Stock Forecasts - newser.com
Using flow based indicators on Third Harmonic Bio Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Is Third Harmonic Bio Inc. stock poised for growthJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com
Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - fiercebiotech.com
Using RSI to spot recovery in Third Harmonic Bio Inc.IPO Watch & Reliable Intraday Trade Plans - newser.com
How to track smart money flows in Third Harmonic Bio Inc.Watch List & Long Hold Capital Preservation Plans - newser.com
Multi factor analysis applied to Third Harmonic Bio Inc.Rate Cut & High Return Trade Opportunity Guides - newser.com
How sentiment analysis helps forecast Third Harmonic Bio Inc.Market Activity Report & High Accuracy Investment Signals - newser.com
Can a trend reversal in Third Harmonic Bio Inc. lead to recoveryRate Cut & Expert Curated Trade Setup Alerts - newser.com
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
Is Third Harmonic Bio Inc a good long term investmentEarnings Date Calendar & Free Exceptional Risk Adjusted Gains - earlytimes.in
Long term hold vs stop loss in CREVWWeekly Profit Report & Daily Chart Pattern Signals - newser.com
Why Sphere Entertainment Co. Class stock could rally stronglyWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Is FULTP stock a dividend growth opportunityNew Guidance & Long-Term Safe Investment Plans - newser.com
Will PJFV stock outperform foreign stocksMarket Rally & AI Driven Price Predictions - newser.com
Can EM Systems Co. Ltd. (EMO) stock sustain double digit ROEEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Best data tools to analyze Third Harmonic Bio Inc. stockWeekly Stock Report & Community Consensus Stock Picks - newser.com
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335 - ADVFN
Is Third Harmonic Bio Inc. stock ready for a breakoutJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Third Harmonic Bio Inc Stock (THRD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.96%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):